|
1
|
Shaw JE, Sicree RA and Zimmet PZ: Global
estimates of the prevalence of diabetes for 2010 and 2030. Diabetes
Res Clin Pract. 87:4–14. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kahn CR, Vicent D and Doria A: Type II
non-insulin-dependent diabetes mellitus. Annu Rev Med. 47:509–531.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chan JC, Cho NH, Tajima N and Shaw J:
Diabetes in the western pacific Region-past, present and future.
Diabetes Res Clin Pract. 103:244–255. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chan JC, Malik V, Jia W, Kadowaki T,
Yajnik CS, Yoon KH and Hu FB: Diabetes in Asia: Epidemiology, risk
factors and pathophysiology. JAMA. 301:2129–2140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu Y, Wang L, He J, Bi Y, Li M, Wang T,
Wang L, Jiang Y, Dai M, Lu J, et al: Prevalence and control of
diabetes in Chinese adults. JAMA. 310:948–958. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferrannini E, Gastaldelli A, Miyazaki Y,
Matsuda M, Mari A and DeFronzo RA: Beta-cell function in subjects
spanning the range from normal glucose tolerance to overt diabetes:
A new analysis. J Clin Endocrinol Metab. 90:493–500. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Warram JH, Martin BC, Krolewski AS,
Soeldner JS and Kahn CR: Slow glucose removal rate and
hyperinsulinemia precede the development of type II diabetes in the
offspring of diabetic parents. Ann Intern Med. 113:909–915. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khan S and Jena G: Valproic acid improves
glucose homeostasis by increasing Beta-Cell proliferation,
function, and reducing its apoptosis through HDAC inhibition in
Juvenile Diabetic Rat. J Biochem Mol Toxicol. Apr 15–2016.(Epub
ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
9
|
John E: Is reduced first-phase insulin
release the earliest detectable abnormality in individuals destined
to develop type 2 diabetes? Diabetes. 51:117–121. 2002. View Article : Google Scholar
|
|
10
|
Seghieri M, Rebelos E, Astiarraga BD,
Baldi S, Mari A and Ferrannini E: Impact of a mild decrease in
fasting plasma glucose on β-cell function in healthy subjects and
patients with type 2 diabetes. Am J Physiol Endocrinol Metab. Apr
12–2016.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Butler AE, Janson J, Bonner-Weir S, Ritzel
R, Rizza RA and Butler PC: β-cell deficit and increased β-cell
apoptosis in humans with type 2 diabetes. Diabetes. 1:102–110.
2003. View Article : Google Scholar
|
|
12
|
World Health Organization: WHO Expert
Committee on Diabetes Mellitus. Second report. World Health Organ
Tech Rep Ser. 646:1–80. 1980.PubMed/NCBI
|
|
13
|
McCoy RG, Van Houten HK, Ross JS, Montori
VM and Shah ND: HbA1c overtesting and overtreatment among US adults
with controlled type 2 diabetes, 2001–13: Observational population
based study. BMJ. 351:h61382015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao W, Wang Q and Yu S: Efficacy, safety
and impact on β-cell function of dipeptidyl peptidase-4 inhibitors
plus metformin combination therapy in patients with type 2 diabetes
and the difference between Asians and Caucasians: A meta-analysis.
J Endocrinol Invest. Apr 12–2016.(Epub ahead of print). View Article : Google Scholar
|
|
15
|
Tura A, Mari A, Winzer C, Kautzky-Willer A
and Pacini G: Impaired beta-cell function in lean normotolerant
former gestational diabetic women. Eur J Clin Invest. 36:22–28.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mari A, Gastaldelli A, Natali A, Ostergard
T, Schmitz O and Ferrannini E: Characterization of beta-cell
function impairment in first-degree relatives of type 2 diabetic
subjects: Modeling analysis of 24-h triple-meal tests. Am J Physiol
Endocrinol Metab. 288:E541–E546. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Elbein SC, Hasstedt SJ, Wegner K and Kahn
SE: Heritability of pancreatic beta-cell function among nondiabetic
members of caucasian familial type 2 diabetic kindreds. J Clin
Endocrinol Metab. 84:1398–1403. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cnop M, Vidal J, Hull RL, Utzschneider KM,
Carr DB, Schraw T, Scherer PE, Boyko EJ, Fujimoto WY and Kahn SE:
Progressive loss of beta-cell function leads to worsening glucose
tolerance in first-degree relatives of subjects with type 2
diabetes. Diabetes Care. 30:677–682. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Malin SK, Samat A, Wolski K, Abood B,
Pothier CE, Bhatt DL, Nissen S, Brethauer SA, Schauer PR, Kirwan JP
and Kashyap SR: Improved acylated ghrelin suppression at 2 years in
obese patients with type 2 diabetes: Effects of bariatric surgery
vs standard medical therapy. Int J Obes (Lond). 38:364–370. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Del Prato S, Marchetti P and Bonadonna RC:
Phasic insulin release and metabolic regulation in type 2 diabetes.
Diabetes. 51(Suppl 1): S109–S116. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen J, Chen Z, Chen C, Zhu X and Han Y:
Impact of incretin on early-phase insulin secretion and glucose
excursion. Endocrine. 44:403–410. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scheen AJ, Castillo MJ and Lefèbvre PJ:
Assessment of residual insulin secretion in diabetic patients using
the intravenous glucagon stimulatory test: Methodological aspects
and clinical applications. Diabetes Metab. 22:397–406.
1996.PubMed/NCBI
|
|
23
|
Kondo Y, Satoh S, Nagakura J, Kimura M,
Nezu U and Terauchi Y: Defining criteria for the introduction of
liraglutide using the glucagon stimulation test in patients with
type 2 diabetes. J Diabetes. 4:571–575. 2013.
|
|
24
|
Ovalle F and Bell DS: Effect of
rosiglitazone versus insulin on the pancreatic beta-cell function
of subjects with type 2 diabetes. Diabetes Care. 27:2585–2589.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Del Prato S: Loss of early insulin
secretion leads to postprandial hyperglycaemia. Diabetologia.
46(Suppl 1): M2–M8. 2003.PubMed/NCBI
|
|
26
|
Bellin MD, Beilman GJ, Dunn TB, Pruett TL,
Chinnakotla S, Wilhelm JJ, Ngo A, Radosevich DM, Freeman ML,
Schwarzenberg SJ, et al: Islet autotransplantation to preserve beta
cell mass in selected patients with chronic pancreatitis and
diabetes mellitus undergoing total pancreatectomy. Pancreas.
42:317–321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Doliba NM, Liu Q, Li C, Chen J, Chen P,
Liu C, Frederick DW, Baur JA, Bennett MJ, Naji A and Matschinsky
FM: Accumulation of 3-hydroxytetradecenoic acid: Cause or corollary
of glucolipotoxic impairment of pancreatic β-cell bioenergetics?
Mol Metab. 4:926–939. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Poitout V and Robertson RP:
Glucolipotoxicity: Fuel excess and beta-cell dysfunction. Endocr
Rev. 29:351–366. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Buchanan TA: Pancreatic beta-cell loss and
preservation in type 2 diabetes. Clin Ther. 25:B32–B46. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leahy JL, Bonner-Weir S and Weir GC:
Beta-cell dysfunction induced by chronic hyperglycemia. Current
ideas on mechanism of impaired glucose-induced insulin secretion.
Diabetes Care. 15:4442–4455. 1992. View Article : Google Scholar
|
|
31
|
Khattab HA, El-Shitany NA, Abdallah IZ,
Yousef FM and Alkreathy HM: Antihyperglycemic potential of grewia
asiatica fruit extract against Streptozotocin-induced hyperglycemia
in rats: Anti-inflammatory and antioxidant mechanisms. Oxid Med
Cell Longev. 2015:5497432015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
van de Bunt M, Manning Fox JE, Dai X,
Barrett A, Grey C, Li L, Bennett AJ, Johnson PR, Rajotte RV,
Gaulton KJ, et al: Transcript expression data from human islets
links regulatory signals from genome-wide association studies for
type 2 diabetes and glycemic traits to their downstream effectors.
PLoS Genet. 11:e10056942015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kaneto H, Xu G, Song KH, Suzuma K,
Bonner-Weir S, Sharma A and Weir GC: Activation of the hexosamine
pathway leads to deterioration of pancreatic beta-cell function
through the induction of oxidative stress. J Biol Chem.
276:31099–31104. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou YP and Grill V: Long-term exposure to
fatty acids and ketones inhibits B-cell functions in human
pancreatic islets of Langerhans. J Clin Endocrinol Metab.
80:1584–1590. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou YP and Grill VE: Long-term exposure
of rat pancreatic islets to fatty acids inhibits glucose-induced
insulin secretion and biosynthesis through a glucose fatty acid
cycle. J Clin Invest. 93:870–876. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jeanne H and Edward S: Beta-cell failure
in the pathogenesis of type 2 diabetes mellitus. Curr Diab Rep.
4:169–175. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Patel A, Barzi F, Jamrozik K, Lam TH,
Ueshima H, Whitlock G and Woodward M: Asia Pacific Cohort Studies
Collaboration: Serum triglycerides as a risk factor for
cardiovascular diseases in the Asia-Pacific region. Circulation.
110:2678–2686. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Taskinen MR: Type 2 diabetes as a lipid
disorder. Curr Mol Med. 5:297–308. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Aldebasi YH, Mohieldein AH, Almansour YS
and Almutairi BL: Dyslipidemia and lipid peroxidation of Saudi type
2 diabetics with proliferative retinopathy. Saudi Med J.
34:616–622. 2013.PubMed/NCBI
|
|
40
|
No authors listed: U.K. prospective
diabetes study 16: Overview of 6 years' therapy of type II
diabetes: A progressive disease. U.K. Prospective diabetes study
group. Diabetes. 44:1249–1258. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Iozzo P, Beck-Nielsen H, Laakso M, Smith
U, Yki-Järvinen H and Ferrannini E: Independent influence of age on
basal insulin secretion in nondiabetic humans. European group for
the study of insulin resistance. J Clin Endocrinol Metab.
84:863–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
van Haeften TW, Pimenta W, Mitrakou A,
Korytkowski M, Jenssen T, Yki-Jarvinen H and Gerich JE: Relative
contributions of beta-cell function and tissue insulin sensitivity
to fasting and postglucose-load glycemia. Metabolism. 49:1318–1325.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kishikawa H, Araki E, Wake N and Shichiri
M: Intensive insulin therapy to prevent the progression of chronic
vascular complications in type 2 diabetes mellitus. Nippon Rinsho.
60(Suppl 9): 140–145. 2002.(In Japanese). PubMed/NCBI
|
